Mycobacterium tuberculosis Extracellular Vesicle Enrichment through Size Exclusion Chromatography
May 19th, 2022
This protocol describes size exclusion chromatography, a facile and reproducible technique for enriching Mycobacterium tuberculosis extracellular vesicles from culture supernatants.
Overview
This protocol describes a facile and reproducible technique for enriching Mycobacterium tuberculosis extracellular vesicles from culture supernatants. It reduces the technical complexity and time required for the enrichment process, providing a gentle alternative to traditional methods.
Key Study Components
Area of Science
- Microbiology
- Cell Biology
- Biochemistry
Background
- Extracellular vesicles (EVs) play a crucial role in intercellular communication.
- Mycobacterium tuberculosis (Mtb) EVs are of interest for their potential role in pathogenesis.
- Traditional methods for isolating EVs can be complex and time-consuming.
- Size exclusion chromatography offers a simpler alternative.
Purpose of Study
- To provide a reproducible method for isolating Mtb EVs.
- To minimize non-EV protein co-enrichment.
- To demonstrate the procedure's ease of use.
Methods Used
- Size exclusion chromatography
- Preparation of a 100-kilodalton molecular weight cutoff centrifugal filter
- Use of PBS for filter preparation
- Gentle handling to preserve EV integrity
Main Results
- High yield of Mtb EVs achieved.
- Minimal co-enrichment of non-EV proteins.
- Procedure demonstrated by Joanie Ryan, a former graduate student.
- Protocol is easy to perform and reproducible.
Conclusions
- Size exclusion chromatography is an effective method for enriching Mtb EVs.
- The technique simplifies the process compared to traditional methods.
- It provides a reliable approach for future research on Mtb EVs.
Frequently Asked Questions
Executive Industry Relevance
Efficient enrichment of Mycobacterium tuberculosis extracellular vesicles (EVs) is critical for advancing discovery-stage research into host-pathogen interactions and antigenic profiling. Size exclusion chromatography (SEC) offers a reproducible, scalable alternative to ultracentrifugation, enabling higher yield and quality of Mtb EVs for downstream applications. This capability supports robust pipeline progression from early discovery through translational research by providing standardized, high-integrity vesicle preparations.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of Mtb EV-mediated host-pathogen interactions for mechanistic de-risking.
- Supports functional validation of antigenic components relevant to vaccine research.
- Facilitates predictive confidence in downstream immunological and compositional studies.
Screening & Assay Development
- Provides reproducible, high-yield EV preparations for assay standardization.
- Minimizes non-EV protein co-enrichment, improving quantitative assay outputs.
- Enables scalable workflows for screening antigenic or functional vesicle properties.
Translational & Preclinical Research
- Delivers high-quality EVs suitable for in vitro and in vivo experimental models.
- Supports continuity from discovery through preclinical validation of vaccine candidates.
- Aligns with compositional and omics-based studies for translational biomarker exploration.
Pipeline & Workflow Integration
SEC-based Mtb EV enrichment integrates into the discovery-to-preclinical continuum, providing a standardized input for mechanistic studies, assay development, and translational research.
- Discovery Biology: Enables hypothesis testing on EV-mediated mechanisms and antigenicity.
- Screening: Delivers reproducible, quantitative EV preparations for assay readiness.
- Analytics: Supports nanoparticle tracking, TEM, and Western blotting for robust characterization.
- Translational Research: Provides vesicle preparations compatible with preclinical and omics workflows.
- Enterprise Reuse: Establishes a scalable, reproducible protocol adaptable to other mycobacterial systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in Mtb EV research.
- Operational Value: Enhances reproducibility, scalability, and standardization across R&D teams.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling high-quality inputs for downstream studies.
- Portfolio Impact: Supports risk-adjusted prioritization of vaccine and biomarker candidates.
Implementation Considerations
- Requires expertise in SEC operation and EV quantification techniques.
- Needs access to SEC instrumentation, nanoparticle tracking, TEM, and Western blotting infrastructure.
- Demands cross-team standardization for reproducibility and data comparability.
- Adaptable to other mycobacterial species with protocol optimization.
- Protein load and dilution strategies may require adjustment for different sample types.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:50
Preparation of Crude Mtb EV Concentrate
2:36
Size Exclusion Chromatography for the Enrichment of Mtb EVs from CFP
5:52
Quantification and Qualification of the Mtb EVs
7:25
Results: Silver Stain and Western Blots by Fraction, TEM Images, and NTA Distribution
8:42
Conclusion
